Skip to content

Comparison Between Propofol-remifentanil Total Intravenous Anesthesia and Desflurane-remifentanil Balanced Anesthesia With Regard to Post-anesthetic Functional Recovery Measured With QoR-40

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01760018
Enrollment
76
Registered
2013-01-03
Start date
2012-12-31
Completion date
2013-01-31
Last updated
2014-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Operation Under General Anesthesia

Keywords

desflurane, total intravenous anesthesia, QoR-40

Brief summary

Total intravenous anesthesia (TIVA) and inhalation anesthesia are both widely and safely used, and there are many clinical trials comparing these on various aspects of anesthesia. However, there have not been studies comparing the quality of recovery from the different methods of general anesthesia. In this study, the investigators compare the functional recovery after general anesthesia in TIVA and inhalation anesthesia with QoR-40 questionnaire.

Interventions

anesthesia is maintained with desflurane and remifentanil (Desflurane group)

anesthesia is maintained with fresofol and remifentanil (TIVA group).

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients who are undergoing thyroid operation belong to ASA class 1 or 2

Exclusion criteria

* patients who are belongs to ASA class 3 or more, * patients who have underlying complicated cardiovascular or psychological disease.

Design outcomes

Primary

MeasureTime frameDescription
QoR-40 scoreat 24 hours later after surgeryQoR-40 score is going to be measured at preoperative period, 24 hours, and 48 hours later after surgery.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026